We use essential cookies for the site to work and optional analytics and marketing cookies. You can accept or reject them — your choice can be changed at any time. Learn more
Tratamento
Clinical trials are revealing how GLP-1 medications perform for adults with mild obesity. Here is what the research says about efficacy, safety, and realistic expectations.
Wondering what happens when you stop taking GLP-1 medication? The rebound effect is a real physiological response. Here's what research shows and how to prepare.
Discover how GLP-1 medications target appetite control at the biological level. Learn about the hormone's journey from gut to brain and why these treatments may help with weight management.
Brazil's ANVISA has approved Tirzepatide (Tirzec) for weight loss. Here's everything you need to know about this dual-agonist medication, how it works, and what to expect.
A clear, factual guide on Mounjaro (tirzepatida) in Brazil: what it does, regulatory status, estimated costs, and what patients should know before starting treatment.
With semaglutide becoming more accessible, many patients wonder if cheaper alternatives like Semavy work as well as the original Ozempic. Here's what the evidence actually shows.
Two people, same medication, completely different doses. The science behind why GLP-1 dose requirements vary so much between patients might surprise you.
Entenda como a semaglutida oral funciona, quem pode se beneficiar dela e o que considerar antes de escolher entre comprimido e injeção para o tratamento com GLP-1.
Entenda como a entrada de fabricantes nacionais de canetas GLP-1 mudou o cenário de prescrição, acesso e custos no tratamento da obesidade no Brasil.
Brazilian pharmacies are tightening their monitoring of GLP-1 weight loss medications. Understand what this means for patients and how to navigate the changing prescription landscape in Brazil.
GLP-1 medications work, but they cost plenty. Here are legitimate ways to reduce what you pay without touching fake pens or contraband supplies.
